Document is current
Any future updates will be listed below
-
Authors
Périan, Séverine
Castellano, Eva https://orcid.org/0000-0003-0858-914X
Costa, Caroline
Martinello, Chiara
Galy, Anne https://orcid.org/0000-0002-0153-4392
Froment, Gisèle
Orentas, Rimas
Valeri, Antonio
Verhoeyen, Els https://orcid.org/0000-0001-9224-5491
-
Funding
Funding for this research was provided by:
Agence Nationale de la Recherche (PEPR-EDITO)
Agence Nationale de la Recherche (PEPR-THERA-B)
Agence Nationale de la Recherche (PEPR-THERA B)
Caring Cross
European Commission (Marie Curie Phd Network GET-IN)
- License Information
-
More Information
Article History
Received: 15 July 2025
Revised: 29 October 2025
Accepted: 9 December 2025
First Online: 19 January 2026
Competing interests
: EV is inventor on the patent on pseudotyping of retroviral particles with BaEV envelope glycoproteins (patent WO 07290918.7)
: NBSGW mice were housed in our animal facility (Plateau de Biologie Expérimentale de la Souris (PBES), Lyon, France). Experiments were performed in accordance with the European Union guidelines upon approval of the protocols by the local ethical committee. (Autorization agreement N° C2EA -15: CECCAPP, Lyon, France). Umbilical cord blood (CB) samples from full-term pregnancies and peripheral blood samples were obtained from healthy donors after informed consent (provided by EFS, Besançon, France) and approval was obtained by the ethical committee of the hospital according to the Helsinki declaration.
